LifeScite

LifeScite Simplifying life science one cell at a time

Semaglutide and tirzepatide, both once weekly injections, have shown significant reduction in body weight with tolerable...
22/02/2021

Semaglutide and tirzepatide, both once weekly injections, have shown significant reduction in body weight with tolerable side effects. These interventions are forecasting a shift in weight loss medication.

https://lifescite.com/new-weight-loss-paradigm-diabetic-drugs-showing-promise-as-treatments/

Semaglutide and tirzepatide, both once weekly injections, have shown significant reduction in body weight with tolerable side effects. These interventions are forecasting a shift in weight loss medication.

A deeper dive into the research published by pharma companies shows that efficacy of COVID vaccines may not be as high a...
19/01/2021

A deeper dive into the research published by pharma companies shows that efficacy of COVID vaccines may not be as high as once thought.

https://lifescite.com/moderna-ceo-is-right-covid-is-here-to-stay/

A deeper dive into the research published by pharma companies shows that efficacy of COVID vaccines may not be as high as once thought.

This study analyzes the effectiveness of certain lockdown interventions on preventing the transmission of COVID. The imp...
28/12/2020

This study analyzes the effectiveness of certain lockdown interventions on preventing the transmission of COVID. The implementation of certain measures over can lower the transmission rate. Read about which ones performed best.

https://lifescite.com/the-government-measures-most-effective-at-limiting-covid-spead/

This study analyzes the effectiveness of certain lockdown interventions on preventing the transmission of COVID. The implementation of certain measures over can lower the transmission rate. Read about which ones performed best.

Amazon launches their online pharmacy delivery service which provides patients with their prescriptions at their doorste...
02/12/2020

Amazon launches their online pharmacy delivery service which provides patients with their prescriptions at their doorstep within days. Does this move foreshadow their next step: to provide virtual care services for patients to speak with doctors online?

https://lifescite.com/telemedicine-in-amazons-future-after-entry-in-prescription-delivery-service/

Amazon launches their online pharmacy delivery service which provides patients with their prescriptions at their doorstep within days. Does this move foreshadow their next step: to provide virtual care services for patients to speak with doctors online?

A panel of experts voted against aducanumab for the treatment of Alzheimer’s disease, claiming the data does not show su...
10/11/2020

A panel of experts voted against aducanumab for the treatment of Alzheimer’s disease, claiming the data does not show sufficient efficacy. Now the final decision lies in the hands of the FDA.

https://lifescite.com/drug-approval-for-aducanumab-gets-shut-down-by-adcom-now-the-fda-must-decide/

A panel of experts voted against aducanumab for the treatment of Alzheimer's disease, claiming the data does not show sufficient efficacy. Now the final decision lies in the hands of the FDA.

CAR-T cells ruled the oncology field for years until their CAR-NK cell counterparts showed equivalent early efficacy wit...
19/10/2020

CAR-T cells ruled the oncology field for years until their CAR-NK cell counterparts showed equivalent early efficacy without the adverse events.

https://lifescite.com/nk-cells-oncologys-next-big-wave/

CAR-T cells ruled the oncology field for years until their CAR-NK cell counterparts showed equivalent early efficacy without the adverse events.

Immunotherapy has been focused on T cells in the last decade. Now, there is a growing interest in NK cells. Here are the...
05/10/2020

Immunotherapy has been focused on T cells in the last decade. Now, there is a growing interest in NK cells. Here are the fundamentals needed to understand the approach to innate immunity.

https://lifescite.com/nk-cells-for-dummies-understanding-the-next-cancer-paradigm/

Immunotherapy has been focused on T-Cells in the last decade. Now, there is a growing interest in NK cells. Here are the fundamentals needed to understand the approach to innate immunity.

PCR testing used to classify COVID cases in the US have set their cut-off too high. This has the potential to diagnose “...
22/09/2020

PCR testing used to classify COVID cases in the US have set their cut-off too high. This has the potential to diagnose “positive” COVID cases, even though patients may be carrying viral loads considered to be non-contagious.

https://lifescite.com/up-to-90-of-us-covid-tests-can-be-false-positives/

PCR testing used to classify COVID cases in the US have set their cut-off too high. This has the potential to diagnose "positive" COVID cases, even though patients may be carrying viral loads considered to be non-contagious.

Trillium Therapeutics’ latest cohort for monotherapy treatment of broad lymphoma shows promising results with a relative...
17/09/2020

Trillium Therapeutics’ latest cohort for monotherapy treatment of broad lymphoma shows promising results with a relatively clean safety profile. This data spiked the attention of Pfizer and Wall Street providing Trillium with $270M to advance their pipeline forward.

https://lifescite.com/trilliums-cd47-monotherapy-data-draws-attention-of-pfizer-and-wall-street/

Trillium Therapeutics' latest cohort for monotherapy treatment of broad lymphoma shows promising results with a relatively clean safety profile. This data spiked the attention of Pzifer and Wall Street providing Trillium with $270M to advance their pipeline forward.

The use of telemedicine skyrocketed at the beginning of COVID, as in-person visits were limited. A NYU study found that ...
15/09/2020

The use of telemedicine skyrocketed at the beginning of COVID, as in-person visits were limited. A NYU study found that adoption has been rising among patients and healthcare providers.

https://lifescite.com/covid-kickstarted-telemedicine-adoption-with-4000-growth/

The use of telemedicine skyrocketed at the beginning of COVID, as in-person visits were limited. A NYU study found that adoption has been rising among patients and healthcare providers.

Public health experts fear that the immunity built up against COVID might not be enough to protect against reinfection. ...
01/09/2020

Public health experts fear that the immunity built up against COVID might not be enough to protect against reinfection. This complicates the development of a vaccine and leaves us at a standstill until more research comes along.

https://lifescite.com/possibility-of-covid-re-infection-doesnt-seem-as-far-off-as-once-thought/

Public health experts fear that the immunity built up against COVID might not be enough to protect against reinfection. This complicates the development of a vaccine and leaves us at a standstill until more research comes along.

The FDA has granted authorization to a new COVID-19 test that returns results in 15 minutes and costs $5/test. It is onl...
01/09/2020

The FDA has granted authorization to a new COVID-19 test that returns results in 15 minutes and costs $5/test. It is only used to screen patients with Covid symptoms. Asymptomatic patients will not be screened with this test. The test requires a prescription and a healthcare provider to adminster it.

https://lifescite.com/abbotts-new-5-15-min-covid-test-a-game-changer-for-symptomatic-patients/

The FDA has granted authorization to a new COVID-19 test that returns results in 15 minutes and costs $5/test. It is only used to screen patients with Covid symptoms. Asymptomatic patients will not be screened with this test. The test requires a prescription and a healthcare provider to adminster it...

Study from Finland showed that L-cysteine in a supplement form was able to reduce hangover symptoms the morning after. R...
01/09/2020

Study from Finland showed that L-cysteine in a supplement form was able to reduce hangover symptoms the morning after. Read the study shortcomings that place findings in doubt.

https://lifescite.com/touted-hangover-cure-not-all-its-made-out-to-be/

Study from Finland showed that L-cysteine in a supplement form was able to reduce hangover symptoms the morning after. Read the study shortcomings that place findings in doubt.

25/08/2020

Address


Alerts

Be the first to know and let us send you an email when LifeScite posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Address
  • Alerts
  • Claim ownership or report listing
  • Want your business to be the top-listed Media Company?

Share